» Articles » PMID: 9363697

The Effectiveness of Ovulation Induction and Intrauterine Insemination in the Treatment of Persistent Infertility: a Meta-analysis

Overview
Journal Hum Reprod
Date 1997 Nov 18
PMID 9363697
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

A systematic review was conducted to evaluate the effectiveness of intrauterine insemination (IUI) with or without ovarian stimulation using gonadotrophin in the treatment of persistent infertility. Relevant randomized controlled trials were identified by a diverse strategy including a hand search of 43 core journals from 1966 to the present. Two approaches to meta-analysis were used to summarize data. First, using a standard Mantel-Haenszel approach, eight trials comparing FSH/IUI with FSH/timed intercourse for unexplained infertility were combined. The common odds ratio for pregnancy was 2.37 [95% confidence interval (CI), 1.43, 3.90], suggesting a significant improvement with IUI following ovulation induction in this patient group. Although the data were statistically homogeneous, clinically important heterogeneity was present. Second, across all diagnostic groups, the independent effects of treatment with follicle stimulating hormone (FSH), clomiphene citrate, IUI, as well as the diagnoses of male factor and endometriosis were assessed using stepwise logistic regression. Based on 5214 cycles reported in 22 trials, the odds ratio for pregnancy associated with FSH use was 2.35 (95% CI, 1.87, 2.94) for IUI, 2.82 (95% CI, 2.18, 3.66) for male factor, 0.48 (95% CI, 0.37, 0.61), and for endometriosis 0.45 (95% CI, 0.27, 0.76). This summary of the best available evidence may prove useful in counselling couples who are considering FSH and/or IUI therapy.

Citing Articles

Predicting success of intrauterine insemination using a clinically based scoring system.

Zippl A, Wachter A, Rockenschaub P, Toth B, Seeber B Arch Gynecol Obstet. 2022; 306(5):1777-1786.

PMID: 36069921 PMC: 9519724. DOI: 10.1007/s00404-022-06758-z.


Mumps Orchitis: Clinical Aspects and Mechanisms.

Wu H, Wang F, Tang D, Han D Front Immunol. 2021; 12:582946.

PMID: 33815357 PMC: 8013702. DOI: 10.3389/fimmu.2021.582946.


A comparison of oral versus injectable ovarian stimulation in IUI in women ≥38 years of age with decreased ovarian reserve.

Frank R, Steiner N, Al Shatti M, Ruiter-Ligeti J, Dahan M Arch Gynecol Obstet. 2021; 303(6):1607-1616.

PMID: 33389112 DOI: 10.1007/s00404-020-05897-5.


Intra-uterine insemination for unexplained subfertility.

Ayeleke R, Asseler J, Cohlen B, Veltman-Verhulst S Cochrane Database Syst Rev. 2020; 3:CD001838.

PMID: 32124980 PMC: 7059962. DOI: 10.1002/14651858.CD001838.pub6.


Strong Evidences of the Ovarian Carcinoma Risk in Women after IVF Treatment: A Review Article.

Farhud D, Zokaei S, Keykhaei M, Yeganeh M Iran J Public Health. 2020; 48(12):2124-2132.

PMID: 31993380 PMC: 6974869.